Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual.
Viral Immunol
; 36(3): 153-162, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36944125
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Viral Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
/
VIROLOGIA
Year:
2023
Document type:
Article
Affiliation country:
China